03.01.2024
The Barbara Davis Center (BDC) has been active in designing and conducting type 1 diabetes (T1D) studies aiming to prevent type 1 diabetes and extend insulin production (the honeymoon) in people with newly diagnosed type 1 diabetes for over 25 years. The BDC is the Colorado home for the Type 1 Diabetes TrialNet and the BDC Type 1 Diabetes Prevention Teams.
Screening for Type 1 Diabetes
As part of the TrialNet Pathway to Prevention Study, the BDC offers free screening to detect risk for T1D by measuring type 1 diabetes-related islet autoantibodies in relatives of people with T1D (https://www.trialnet.org/) under age 45 years. Screening is offered at the BDC or remotely through a home finger poke kit or commercial lab (Quest/LabCorp) kit.
Signing up for screening for T1D risk is easy, and we have several options to provide more information, schedule a screening appointment or send you a home or laboratory screening kit:
Principal investigator: Andrea Steck, MD
Study coordinator: Hali Broncucia (303) 724-7526
